sglt2 inhibitors vs glp-1 3. Integration of GLP-1RA or SGLT2i in Patients With T2D With or at Risk of atherosclerotic CVD Journal of Lancaster General Health

For others, it may be lowering the dose to reduce side effects, cost, or treatment burden

The same drug lists for $155 in Canada and just $59 in Germany

[DOI] [PubMed] [Google Scholar] 144.Nicolau J., Tamayo M.I., Sanchis P., Pujol A., Perez-Bec G., Sfondrini G., Masmiquel L

They also appear to decrease markers of systemic inflammation , which is critical because chronic inflammation fuels atherosclerosis (plaque buildup in arteries)

10.1038/nm.3128 46 KimE

The incidence of adverse effects, particularly gastrointestinal complications, psychiatric disorders, and ocular problems, highlights the critical need for thorough patient assessment and continuous monitoring to ensure both the safety and effectiveness of treatment